Elixinol Global

An executive from international CBD brand Elixinol has been appointed to the board of directors at the U.S. Hemp Authority — one of the industry’s self-regulatory bodies. “From the start, Elixinol has gone above and beyond when it comes to product efficacy and transparency,” Elixinol CEO for the Americas Tom Siciliano said about his appointment.
Hemp-derived CBD supplement maker Elixinol shed half of its global workforce and shuttered production lines in the first half of this year in response to market decline stemming from the global COVID-19 pandemic. Now the Australian company is looking to leverage a leaner operation and focus on its core CBD brands for future success. Talking
This is the second part of an interview with Elixinol CEO Oliver Horn. Read his insights on leadership here. In a recent presentation, you said the company was ?well-positioned to navigate the regulatory environment that is dynamic, and we remain very positive that regulatory changes are working in our favor.? What makes Elixinol well-positioned to
International CBD brand Elixinol has appointed a former supplement-industry executive as its new global CEO ? the Australian company?s second management reshuffle in less than a month. Oliver Horn formerly served as head of Swisse Wellness for Australia, New Zealand and North America. He takes over from Stratos Karousos as Elixinol Global CEO with immediate effect,
The coronavirus pandemic has upended the economic landscape and forced businesses of all sizes and industries to suspend operations, cancel events and furlough tens of thousands of workers. With markets in freefall and states imposing lockdowns across the U.S., some have argued that hemp-derived supplements industry could see an increase in demand as consumers seek